Zum Inhalt springen

Letermovir

https://www.dsmpharmaceuticalproducts.com/web/image/product.template/61555/image_1920?unique=be6aa15
Applications Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. References Kropeit, D. et al.: Brit. J. Clin Pharmacol., 83, 2678 (2017); Kim, E. et al.: Drugs. 78, 147 (2018);

147,42 147.42 USD 147,42

147,42

Not Available For Sale

( 0,00 / Einheit(en))

Diese Kombination existiert nicht.

Geschäftsbedingungen
30-Tage-Geld-zurück-Garantie
Versand: 2-3 Geschäftstage